Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen

Daniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, Andrea CALCAGNO, Vanni Borghi, Caterina Gori, Ada Bertoli, William Gennari, Rita Bellagamba, Antonella Castagna, Alessandra Latini, Carmela Pinnetti, Stefania Cicalini, Annalisa Saracino, Giuseppe Lapadula, Stefano Rusconi, Francesco Castelli, Simona Di Giambenedetto, Massimo Andreoni, Giovanni Di PerriAndrea Antinori, Cristina Mussini, Francesca Ceccherini-Silberstein, Antonella D'Arminio Monforte, Carlo F Perno, Maria M Santoro

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Pre-cART (combined antiretroviral therapy) plasma viral load >500,000 copies/mL has been associated with a lower probability of achieving virological suppression, while few data about its role on maintenance of virological suppression are available. In this study we aimed to clarify whether high levels of pre-cART viremia are associated with virological rebound (VR) after virological suppression.
Lingua originaleInglese
pagine (da-a)1-8
Numero di pagine8
RivistaAntiviral Therapy
DOI
Stato di pubblicazionePubblicato - 2019

Fingerprint

Entra nei temi di ricerca di 'Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen'. Insieme formano una fingerprint unica.

Cita questo